AbCellera Biologics Inc. announced that Neil Berkley has been appointed as Chief Business Officer (CBO). Mr. Berkley’s role will include leading the strategy and continued growth of the company’s partnership business, which currently includes a diverse portfolio of more than 100 programs with drug developers of all sizes. Mr. Berkley has more than 20 years of strategic planning and corporate and business development experience across a wide range of transactions and therapeutic indications. He joins the company from Halozyme Therapeutics.